Inventor
Qiuping Wang
Inventor
Bethany, CT, US
Overview
Patents· 52 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
A61KPreparations for medical, dental or toiletry purposes20%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium15%
C07BGeneral methods of organic chemistry10%
C07KPeptides3%
Y02ATechnologies for adaptation to climate change2%
C12NMicroorganisms or enzymes1%
C12YEnzymes1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
PatentTitleYear
10,822,352Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders202010,807,952Compounds for treatment of immune inflammatory disorders202010,689,409Amino compounds for treatment of complement mediated disorders202010,660,876Amino compounds for treatment of medical disorders202010,662,175Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders202010,550,140Ether compounds for treatment of complement mediated disorders202010,464,956Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders201910,428,095Compounds for treatment of complement mediated disorders201910,428,094Amide compounds for treatment of complement mediated disorders201910,385,097Ether compounds for treatment of medical disorders201910,370,394Carbamate, ester, and ketone compounds for treatment of complement mediated disorders201910,301,336Phosphonate compounds for treatment of complement mediated disorders201910,287,301Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders201910,253,053Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders201910,236,514Lithium ion flow battery201910,189,869Amino compounds for treatment of complement mediated disorders201910,138,225Amide compounds for treatment of medical disorders201810,106,563Ether compounds for treatment of complement mediated disorders201810,100,072Phosphonate compounds for treatment of complement mediated disorders201810,092,584Compounds for the treatment of medical disorders201810,092,547Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero- heteraphanes and metallocenes useful for treating HCV infections201810,087,203Compounds for treatment of complement mediated disorders201810,081,645Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders201810,011,612Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders201810,005,802Amide compounds for treatment of complement mediated disorders201810,000,516Phosphonate compounds for treatment of medical disorders20189,833,440Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections20179,828,396Alkyne compounds for treatment of complement mediated disorders20179,796,741'Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders'20179,758,537'Compounds for treatment of complement mediated disorders'20179,732,104'Ether compounds for treatment of complement mediated disorders'20179,732,103'Carbamate, ester, and ketone compounds for treatment of complement mediated disorders'20179,695,205'Amide compounds for treatment of complement mediated disorders'20179,663,543'Phosphonate compounds for treatment of complement mediated disorders'20179,598,446'Amino compounds for treatment of complement mediated disorders'20179,592,222'Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections'20179,474,742'Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections'20169,468,629'Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections'20169,273,082'Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections'20169,125,904'Biphenyl imidazoles and related compounds useful for treating HCV infections'20158,946,422'8-methoxy-9H-isothiazolo[5,4-B]quinoline-3,4-diones and related compounds as anti-infective agents'20158,809,313'Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections'20148,173,636'Hydroxylthienoquinolones and related compounds as anti-infective agents'20128,138,346'Method for synthesis of 8-alkoxy-9H-isothiazolo[5,4-B]quinoline-3,4-diones'20128,114,888'Isothiazoloquinolones and related compounds as anti-infective agents'20128,044,204'8-methoxy-9H-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents'20117,902,365'Method for synthesis of 8-alkoxy-9H-isothiazolo[5,4-B]quinoline-3,4-diones'20117,199,128'8-N-substituted-2H-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents'20076,673,809'Tricyclic compounds as MRP1-inhibitors'20046,350,866'Streptococcus pneumoniae gene sequence FtsZ'20026,136,557'Strepococcus pneumoniae gene sequence FtsH'20005,958,730'Streptococcus pneumoniae gene sequence FtsY'1999Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1999–2002Based in Indianapolis, IN, US· patent location history
2004Based in Hamden, CT, US· patent location history
2007–2020Patents assigned to ACHILLION PHARMACEUTICALS INC (47)· patent assignee history
2007–2020Based in Bethany, CT, US· patent location history
2012–2015Patents assigned to WANG QIUPING (6)· patent assignee history
2012–2015Patents assigned to WILES JASON ALLAN (6)· patent assignee history
2012–2015Patents assigned to DESHPANDE MILIND (5)· patent assignee history
2012–2015Patents assigned to HASHIMOTO AKIHIRO (5)· patent assignee history
2019Based in Beijing, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ACHILLION PHARMACEUTICALS INC | 47 | 2007–2020 |
| WANG QIUPINGself | 6 | 2012–2015 |
| WILES JASON ALLAN | 6 | 2012–2015 |
| DESHPANDE MILIND | 5 | 2012–2015 |
| HASHIMOTO AKIHIRO | 5 | 2012–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Bethany, CT, US | 47 | 2007–2020 |
| Indianapolis, IN, US | 3 | 1999–2002 |
| Beijing, CN | 1 | 2019 |
| Hamden, CT, US | 1 | 2004 |